In HNSCC, high expression of B7-H3 is associated with a poorer prognosis and positively correlated with larger tumour size, later clinical stage, lower patient survival and infiltration of M2 macrophages and myeloid-derived suppressor cells (MDSCs) [24]. Here, CD276 is linked to neoplasm.